These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 24593212
1. Amyloid A amyloidosis in a Japanese patient with familial Mediterranean fever associated with homozygosity for the pyrin variant M694I/M694I. Nakamura T, Migita K, Ando Y, Takaoka H, Suzushima H, Shiraishi N. Mod Rheumatol; 2014 Mar; 24(2):349-52. PubMed ID: 24593212 [Abstract] [Full Text] [Related]
2. Serum amyloid A1 -13 T/C alleles in Turkish familial Mediterranean fever patients with and without amyloidosis. Akar N, Hasipek M, Oztürk A, Akar E, Tekin M. J Nephrol; 2006 Mar; 19(3):318-21. PubMed ID: 16874691 [Abstract] [Full Text] [Related]
3. Predicting genetic risk factors for AA amyloidosis in Algerian patients with familial Mediterranean fever. Ait-Idir D, Djerdjouri B, Latreche K, Sari-Hamidou R, Khellaf G. Mol Genet Genomics; 2024 Mar 07; 299(1):25. PubMed ID: 38451362 [Abstract] [Full Text] [Related]
4. The M694I/M694I genotype: A genetic risk factor of AA-amyloidosis in a group of Algerian patients with familial Mediterranean fever. Ait-Idir D, Djerdjouri B, Bouldjennet F, Taha RZ, El-Shanti H, Sari-Hamidou R, Khellaf G, Benmansour M, Benabadji M, Haddoum F. Eur J Med Genet; 2017 Mar 07; 60(3):149-153. PubMed ID: 27956278 [Abstract] [Full Text] [Related]
6. MEFV and SAA1 genotype associations with clinical features of familial Mediterranean fever and amyloidosis in Armenia. Atoyan S, Hayrapetyan H, Sarkisian T, Ben-Chetrit E. Clin Exp Rheumatol; 2016 Mar 07; 34(6 Suppl 102):72-76. PubMed ID: 27791951 [Abstract] [Full Text] [Related]
7. [Familial Mediterranean fever as representative autoinflammatory disease]. Yamazaki K, Yamazaki T, Masumoto J, Suzuki A, Yazaki M, Agematsu K. Rinsho Byori; 2009 Apr 07; 57(4):371-81. PubMed ID: 19489440 [Abstract] [Full Text] [Related]
8. Amyloidosis in familial Mediterranean fever patients: correlation with MEFV genotype and SAA1 and MICA polymorphisms effects. Medlej-Hashim M, Delague V, Chouery E, Salem N, Rawashdeh M, Lefranc G, Loiselet J, Mégarbané A. BMC Med Genet; 2004 Feb 10; 5():4. PubMed ID: 15018633 [Abstract] [Full Text] [Related]
10. MEFV mutation analysis of familial Mediterranean fever in Japan. Tomiyama N, Higashiuesato Y, Oda T, Baba E, Harada M, Azuma M, Yamashita T, Uehara K, Miyazato A, Hatta K, Ohya Y, Iseki K, Jinno Y, Takishita S. Clin Exp Rheumatol; 2008 Feb 10; 26(1):13-7. PubMed ID: 18328141 [Abstract] [Full Text] [Related]
11. Successful treatment with humanized anti-interleukin-6 receptor antibody (tocilizumab) in a case of AA amyloidosis complicated by familial Mediterranean fever. Hamanoue S, Suwabe T, Hoshino J, Sumida K, Mise K, Hayami N, Sawa N, Takaichi K, Fujii T, Ohashi K, Yazaki M, Ikeda S, Ubara Y. Mod Rheumatol; 2016 Jul 10; 26(4):610-3. PubMed ID: 25619282 [Abstract] [Full Text] [Related]
13. Familial Mediterranean fever (FMF) and renal AA amyloidosis--phenotype-genotype correlation, treatment and prognosis. Ben-Chetrit E. J Nephrol; 2003 Jul 10; 16(3):431-4. PubMed ID: 12832747 [Abstract] [Full Text] [Related]
14. The rate and significance of type 1/type 2 serum amyloid A protein gene polymorphisms in patients with ankylosing spondylitis and amyloidosis. Yildirim Cetin G, Ganiyusufoglu E, Solmaz D, Cagatay Y, Yılmaz Oner S, Erer B, Sagliker HS, Avci AB, Akar S, Pamuk ON, Kılınc M, Kasifoglu T, Direskeneli H, Gul A, Sayarlioglu M. Amyloid; 2015 Jul 10; 22(3):207-8. PubMed ID: 26300108 [Abstract] [Full Text] [Related]
15. MEFV mutations in Japanese rheumatoid arthritis patients. Migita K, Nakamura T, Maeda Y, Miyashita T, Koga T, Tanaka M, Nakamura M, Komori A, Ishibashi H, Origuchi T, Ida H, Kawasaki E, Yasunami M, Eguchi K. Clin Exp Rheumatol; 2008 Jul 10; 26(6):1091-4. PubMed ID: 19210876 [Abstract] [Full Text] [Related]
16. The contribution of SAA1 polymorphisms to Familial Mediterranean fever susceptibility in the Japanese population. Migita K, Agematsu K, Masumoto J, Ida H, Honda S, Jiuchi Y, Izumi Y, Maeda Y, Uehara R, Nakamura Y, Koga T, Kawakami A, Nakashima M, Fujieda Y, Nonaka F, Eguchi K, Furukawa H, Nakamura T, Nakamura M, Yasunami M. PLoS One; 2013 Jul 10; 8(2):e55227. PubMed ID: 23437051 [Abstract] [Full Text] [Related]
18. A severe autosomal-dominant periodic inflammatory disorder with renal AA amyloidosis and colchicine resistance associated to the MEFV H478Y variant in a Spanish kindred: an unusual familial Mediterranean fever phenotype or another MEFV-associated periodic inflammatory disorder? Aldea A, Campistol JM, Arostegui JI, Rius J, Maso M, Vives J, Yagüe J. Am J Med Genet A; 2004 Jan 01; 124A(1):67-73. PubMed ID: 14679589 [Abstract] [Full Text] [Related]
19. Living kidney transplantation between brothers with unrecognized renal amyloidosis as the first manifestation of familial Mediterranean fever: a case report. Peces R, Afonso S, Peces C, Nevado J, Selgas R. BMC Med Genet; 2017 Aug 31; 18(1):97. PubMed ID: 28859624 [Abstract] [Full Text] [Related]
20. Autosomal dominant familial Mediterranean fever in Northern European Caucasians associated with deletion of p.M694 residue-a case series and genetic exploration. Rowczenio DM, Iancu DS, Trojer H, Gilbertson JA, Gillmore JD, Wechalekar AD, Tekman M, Stanescu HC, Kleta R, Lane T, Hawkins PN, Lachmann HJ. Rheumatology (Oxford); 2017 Feb 31; 56(2):209-213. PubMed ID: 27150194 [Abstract] [Full Text] [Related] Page: [Next] [New Search]